Antitumor activity of chLpMab-2, a human-mouse chimeric cancer-specific antihuman podoplanin antibody, via antibody-dependent cellular cytotoxicity.
about
Antitumor activity of a newly developed monoclonal antibody against ROR1 in ovarian cancer cells.Plasma soluble podoplanin is a novel marker for the diagnosis of tumor occurrence and metastasis.C-Type Lectin-Like Receptors As Emerging Orchestrators of Sterile Inflammation Represent Potential Therapeutic Targets.Podoplanin - an emerging cancer biomarker and therapeutic target.Anti-podocalyxin antibody exerts antitumor effects via antibody-dependent cellular cytotoxicity in mouse xenograft models of oral squamous cell carcinoma.
P2860
Antitumor activity of chLpMab-2, a human-mouse chimeric cancer-specific antihuman podoplanin antibody, via antibody-dependent cellular cytotoxicity.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Antitumor activity of chLpMab- ...... pendent cellular cytotoxicity.
@en
Antitumor activity of chLpMab- ...... pendent cellular cytotoxicity.
@nl
type
label
Antitumor activity of chLpMab- ...... pendent cellular cytotoxicity.
@en
Antitumor activity of chLpMab- ...... pendent cellular cytotoxicity.
@nl
prefLabel
Antitumor activity of chLpMab- ...... pendent cellular cytotoxicity.
@en
Antitumor activity of chLpMab- ...... pendent cellular cytotoxicity.
@nl
P2093
P2860
P356
P1433
P1476
Antitumor activity of chLpMab- ...... pendent cellular cytotoxicity.
@en
P2093
Akiko Kunita
Masashi Fukayama
Mika K Kaneko
Satoshi Ogasawara
Shinji Abe
Shinji Yamada
Takuro Nakamura
Yasuhiko Nishioka
Yuki Fujii
P2860
P304
P356
10.1002/CAM4.1049
P407
P577
2017-03-23T00:00:00Z